PAVmed Inc expected to post a loss of 47 cents a share - Earnings Preview

PAVmed

11/08/2026 22:09

PAVmed Inc PAVM.OQ PAVM.O is expected to  show a rise in quarterly revenue when it reports  results on August 13 for the period ending June 30 2026
The New York City-based  company is expected to report a 700.0% increase in revenue to $48 thousand from $6 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
​LSEG's mean analyst estimate for PAVmed Inc is for a loss of 47 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for PAVmed Inc is $36.00, about 657.9% above its last closing price of $4.75
This summary was machine generated August 11 at 21:09 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)